Business
Fed chair Powell raises hopes of US rate cut
Jerome Powell, the head of the US central bank, has given a rocket boost to expectations that there will be an interest rate cut in September, a move President Trump has been demanding for months.
Speaking to central bankers gathered at Jackson Hole, Wyoming, Powell also argued that the inflationary impact of Trump’s tariffs could prove temporary.
But he did not, as some had expected, address the additional challenges he has faced in recent months: the political pressure exerted on the US central bank, Trump’s barrage of name-calling and demands for Powell to be removed from his post.
The shift to a more “dovish” stance, suggesting an easing of the cost of borrowing, sent share prices higher.
Economists and investors were already expecting borrowing rates to come down from their current 4.25 to 4.5% range. Recent weakness in the US jobs market raised those expectations further, but the impact on prices of Trump’s sweeping tariffs had raised doubts.
“In the near term, risks to inflation are tilted to the upside, and risks to employment to the downside—a challenging situation,” Powell said.
Central banks typically cut rates to boost growth if there are signs of slowing economy and falling employment, as it makes it cheaper for consumers and businesses to borrow.
But boosting growth has to be balanced with keeping a check on rising prices. Higher interest rates can help control inflation, which is often seen as a central bank’s main priority.
Powell said the effects of tariffs on consumer prices were now “clearly visible” but said that there was a “reasonable” case to be made that inflation would be “relatively short lived – a one-time shift in the price level”.
He said it would take time for the price changes to work their way through, but he downplayed the likelihood of inflation becoming embedded due to increased wage demands, or higher inflation expectations.
As interest rates were already “in restrictive territory” – high enough to be having a dampening impact on economic activity – Powell suggested that “the shifting balance of risks may warrant adjusting our policy stance”.
The only time Powell appeared to make reference to the extra pressure exerted by the Trump presidency was when he cautioned against a presumption that a September rate cut was set in stone.
He said: “Monetary policy is not on a preset course”.
Members of the policy making committee would take the decision “based solely on their assessment of the data and its implications for the economic outlook and the balance of risks.
“We will never deviate from that approach,” he said.
Friday’s speech is likely to be Powell’s final address to the annual gathering of the country’s central bankers in Jackson Hole, as his term comes to an end in May 2026.
He was appointed chairman of the Federal Reserve by Trump in 2017.
Since then however Trump has expressed increasing animosity, hurling personal insults at the central banker, including calling him a “numbskull” and a “stubborn moron”, because he did not support the president’s calls for rapid, large cuts to borrowing rates.
Trump has also publicly raised the idea of removing Powell from his post early, although it is not clear that he has the legal authority to do so.
Earlier this week the president called for another of the Fed’s officials, Lisa Cook, to resign, over alleged mortgage fraud. She said she would not be “bullied” into leaving.
Investors welcomed Powell’s speech, pushing the main American share indexes sharply higher in the minutes after he began speaking. By the end of the day’s trading in the US, the broad S&P 500 index was around 1.5% higher.
Brian Jacobsen, chief economist at Annex Wealth Management, said the Fed had opted against being the “party-pooper”.
“Chair Powell has shown he has an open mind to reading the data tea leaves,” he said.
Diane Swonk, chief economist at KPMG US said: “Powell opened the door a little wider to a cut in rates in September.”
But she said the Fed clearly remained concerned about the risk of rising prices.
“There is more caution than the markets are giving him credit for,” she said.
Capital Economics’ deputy chief North America economist, Stephen Brown, said that while a September rate cut now looked “almost nailed on”, higher job creation or “much more concerning” price data in August could still trigger a delay.
Business
Anthropic officially designated a supply chain risk by Pentagon
The supply chain risk designation of the artificial intelligence firm is a first for a US company.
Source link
Business
FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
Thomas Fuller | SOPA Images | Lightrocket | Getty Images
UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.
The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.
“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”
The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.
UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.
The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”
UniQure didn’t immediately comment.
The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.
Business
US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India
The average long-term US mortgage rate edged higher this week, ending a three-week decline as bond yields rose amid oil-price pressures linked to the war with Iran.The benchmark 30-year fixed mortgage rate increased to 6% from 5.98% last week, mortgage buyer Freddie Mac said on Thursday. A year ago, the average rate stood at 6.63%, AP reported.The modest uptick breaks a three-week slide in borrowing costs, with mortgage rates having hovered close to the 6% mark for most of this year. Last week’s average had marked the first time the rate dipped below 6% since September 2022, reaching its lowest level in nearly three and a half years.Mortgage rates are influenced by several factors, including the Federal Reserve’s interest-rate policy, investor expectations about inflation and economic growth, and movements in the bond market.They typically track the direction of the 10-year US Treasury yield, which lenders use as a benchmark for pricing home loans.The 10-year Treasury yield rose to 4.14% at midday Thursday, up from around 4% a week earlier.Treasury yields have moved higher in recent days as rising oil prices added fresh inflation concerns, potentially complicating the Federal Reserve’s plans to cut interest rates.
-
Business1 week agoAttock Cement’s acquisition approved | The Express Tribune
-
Politics1 week agoWhat are Iran’s ballistic missile capabilities?
-
Business7 days agoIndia Us Trade Deal: Fresh look at India-US trade deal? May be ‘rebalanced’ if circumstances change, says Piyush Goyal – The Times of India
-
Politics1 week agoUS arrests ex-Air Force pilot for ‘training’ Chinese military
-
Fashion1 week agoPolicy easing drives Argentina’s garment import surge in 2025
-
Business6 days agoGreggs to reveal trading amid pressure from cost of living and weight loss drugs
-
Sports1 week agoSri Lanka’s Shanaka says constant criticism has affected players’ mental health
-
Sports6 days agoLPGA legend shares her feelings about US women’s Olympic wins: ‘Gets me really emotional’
